�On September 10, 2008, at
6 p.m. E.T., preeminent prostate
cancer specialists from
Dana-Farber/Brigham and Women's Cancer Center volition webcast their 10th
Annual Symposium on Prostate Cancer, a patient role education event
featuring the newest advances in treatment, screening, and prevention
of prostate cancer.
For this webcast, Anthony V. D'Amico, MD, PhD, Chief of the Prostate
Cancer Radiation
Oncology Service, Philip W. Kantoff, MD, Director of
the Lank Center for Genitourinary Oncology, Jerome P. Richie, MD,
Chief of Urologic Surgery, and Jim C. Hu, MD, MPH, Director of
Minimally Invasive Urologic Oncology, will discuss the up-to-the-minute
approaches and research in the prevention, diagnosis, and treatment
of prostate cancer.
The Symposium will provide an overview of new treatment advances and
related outcomes, including new medical therapies, radioactive seed
implantation techniques, robotic-assisted surgery, nerve-sparing
techniques, image-guided radiation therapy approaches, and the nigh
recent results of clinical trials. Also, the up-to-the-minute findings in the
genetic science of prostate cancer and prostate cancer screening guidelines
will be discussed.
The second nigh common genus Cancer in men, prostate cancer is most often
diagnosed in work force over the age of 50. The National Cancer Institute
estimates more than 186,000 new cases of prostate cancer in the
United States in 2008, and more than 28,000 deaths from the disease.
More common in African-American men than in Caucasian men, studies
have as well shown that a man's risk is doubled if his father or brother
has the disease.
Brigham and Women's Hospital (BWH) is a 777-bed nonprofit teaching
affiliate of Harvard Medical School and a founding member of Partners
HealthCare, an integrated health care delivery network. In July of
2008, the hospital opened the Carl J. and Ruth Shapiro Cardiovascular
Center, the most advanced center of its kind. BWH is committed to
excellence in patient care with expertise in virtually every
specialty of medicine and surgery. The BWH medical preeminence dates
back to 1832, and today that rich history in clinical care is coupled
with its national leadership in quality melioration and patient
safety initiatives and its dedication to educating and training the
next generation of health care professionals. Through investigation
and uncovering conducted at its Biomedical Research Institute (BRI),
BWH is an international leader in basic, clinical and translational
research on human diseases, involving more than 860
physician-investigators and far-famed biomedical scientists and faculty
supported by more than $416 M in backing. BWH is also home to major
landmark epidemiological population studies, including the Nurses' and
Physicians' Health Studies and the Women's Health Initiative. For
more information around BWH, please visit hypertext transfer protocol://www.brighamandwomens.org
To view a preview of this program and read more visit OR-Live VNR: http://www.OR-Live.com
More info
